OraSure Technologies, Inc. (OSUR) Shares Sold by EAM Investors LLC

EAM Investors LLC lowered its holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) by 28.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 295,349 shares of the medical instruments supplier’s stock after selling 116,325 shares during the quarter. OraSure Technologies comprises approximately 0.8% of EAM Investors LLC’s investment portfolio, making the stock its 4th largest holding. EAM Investors LLC owned about 0.51% of OraSure Technologies worth $5,098,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Alps Advisors Inc. grew its position in OraSure Technologies by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 43,257 shares of the medical instruments supplier’s stock valued at $747,000 after purchasing an additional 111 shares during the period. PNC Financial Services Group Inc. boosted its holdings in OraSure Technologies by 0.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 46,588 shares of the medical instruments supplier’s stock worth $602,000 after acquiring an additional 242 shares during the last quarter. Profund Advisors LLC boosted its holdings in OraSure Technologies by 2.8% during the 2nd quarter. Profund Advisors LLC now owns 10,903 shares of the medical instruments supplier’s stock worth $188,000 after acquiring an additional 293 shares during the last quarter. Timber Hill LLC boosted its holdings in OraSure Technologies by 3.2% during the 2nd quarter. Timber Hill LLC now owns 11,597 shares of the medical instruments supplier’s stock worth $200,000 after acquiring an additional 363 shares during the last quarter. Finally, Wellington Management Group LLP boosted its holdings in OraSure Technologies by 0.5% during the 1st quarter. Wellington Management Group LLP now owns 111,970 shares of the medical instruments supplier’s stock worth $1,448,000 after acquiring an additional 587 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

In related news, insider Brian Smith sold 3,075 shares of the stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $21.09, for a total transaction of $64,851.75. Following the sale, the insider now directly owns 24,540 shares of the company’s stock, valued at $517,548.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Douglas A. Michels sold 290,495 shares of the stock in a transaction on Tuesday, June 27th. The shares were sold at an average price of $16.75, for a total value of $4,865,791.25. Following the sale, the chief executive officer now directly owns 894,012 shares in the company, valued at $14,974,701. The disclosure for this sale can be found here. Insiders have sold 960,173 shares of company stock valued at $18,752,210 over the last 90 days. Corporate insiders own 6.40% of the company’s stock.

A number of research firms have issued reports on OSUR. Zacks Investment Research downgraded shares of OraSure Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, September 19th. Canaccord Genuity reaffirmed a “buy” rating and set a $22.00 price objective on shares of OraSure Technologies in a report on Tuesday, September 19th. Jefferies Group LLC reaffirmed a “buy” rating and set a $20.00 price objective on shares of OraSure Technologies in a report on Tuesday, September 12th. BidaskClub downgraded shares of OraSure Technologies from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Finally, Stephens reaffirmed an “overweight” rating and set a $19.00 price objective (up from $14.00) on shares of OraSure Technologies in a report on Tuesday, July 11th. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $18.04.

TRADEMARK VIOLATION WARNING: “OraSure Technologies, Inc. (OSUR) Shares Sold by EAM Investors LLC” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/2914581/orasure-technologies-inc-osur-shares-sold-by-eam-investors-llc.html.

OraSure Technologies, Inc. (NASDAQ OSUR) traded up 0.60% during trading on Friday, reaching $21.74. 436,293 shares of the company’s stock were exchanged. OraSure Technologies, Inc. has a 12 month low of $7.09 and a 12 month high of $22.25. The firm has a 50 day moving average of $20.72 and a 200-day moving average of $16.18. The stock has a market cap of $1.29 billion, a PE ratio of 40.18 and a beta of 1.57.

OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.02. OraSure Technologies had a return on equity of 15.64% and a net margin of 22.29%. The firm had revenue of $40.18 million during the quarter, compared to the consensus estimate of $36.54 million. During the same period last year, the company earned $0.07 earnings per share. The company’s revenue was up 28.1% on a year-over-year basis. On average, equities research analysts anticipate that OraSure Technologies, Inc. will post $0.48 earnings per share for the current fiscal year.

About OraSure Technologies

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2017 Ticker Report. Google+.